Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1999
12/16/1999WO1999063981A2 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999WO1999063971A1 Micro-osmotic controlled drug delivery systems
12/16/1999WO1999063970A1 Delavirdine tablet formulation
12/16/1999WO1999063968A1 Aqueous preparations containing hardly soluble drug
12/16/1999WO1999063967A1 Enhanced intra vaginal devices
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063934A2 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063932A2 Multibinding agents that modulate the 5-ht transporter
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999WO1999055736A3 Derivatives of arabinogalactan and compositions including the same
12/16/1999WO1999055348A3 Stabilised virus preparation
12/16/1999DE19826503A1 Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Chitosan und Phospholipiden Cosmetic and dermatological preparations containing chitosan and phospholipids
12/16/1999DE19826118A1 Wasserhaltige kosmetische oder pharmazeutische Stifte Hydrous cosmetic or pharmaceutical sticks
12/16/1999CA2334760A1 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
12/16/1999CA2334745A1 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein
12/16/1999CA2334296A1 Enhanced intra vaginal devices
12/16/1999CA2333890A1 Inhibition of coagulation in blood and blood products
12/16/1999CA2333657A1 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999CA2332314A1 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells
12/16/1999CA2330211A1 Formulations for electroporation
12/16/1999CA2329942A1 Therapeutic and diagnostic domain 1 .beta.2gpi polypeptides and methods of using same
12/16/1999CA2321274A1 Novel antiviral compounds
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999CA2321162A1 Novel antibacterial compounds
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999CA2320241A1 Multivalent macrolide antibiotics
12/16/1999CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319153A1 Novel sodium channel drugs and uses
12/16/1999CA2319142A1 Novel therapeutic agents for membrane transporters
12/16/1999CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318901A1 Novel calcium channel drugs and uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318806A1 Multibinding agents that modulate the 5-ht transporter
12/16/1999CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999CA2301042A1 Micro-osmotic controlled drug delivery systems
12/15/1999EP0964000A1 Excipient and disintegrant composition, process for obtaining the same and its use
12/15/1999EP0963758A2 Synthetic polyaminoacid complexes for delivery of nucleic acids to target cells
12/15/1999EP0963209A2 Improvements in or relating to diagnostic/therapeutic agents
12/15/1999EP0963196A2 Hyaluronic drug delivery system
12/15/1999EP0805676B1 Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
12/15/1999EP0685457B1 Glycerol derivative, device and pharmaceutical composition
12/15/1999EP0650354B1 Solid and liquid solutions of drugs which are not readily soluble in water
12/15/1999EP0587840B1 Bioartificial endocrine device
12/15/1999EP0414730B1 Chemical Compounds and pharmaceutical compositions capable of releasing a drug
12/15/1999CN1238769A Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them and gel compositions
12/15/1999CN1238700A Improvents in or relating to diagnostic/therapeutic agents
12/15/1999CN1238695A Topical composition for preventing or treating bacterial skin infections
12/15/1999CN1238691A Liquid alendronate preparation
12/15/1999CN1238690A Improved pharmaceutical compositions
12/15/1999CN1238687A An oil composition of dihydropolyprenols
12/15/1999CN1238214A Exterior-applied medicine for treating trichomonas vaginitis and its preparing method
12/15/1999CN1238181A Nefazodone dosage form
12/15/1999CN1047402C Process for producing synthetic gene of encoding polyporus seed storage albumen
12/15/1999CN1047329C Multi-dentate heterodesmic Rh catalyst and its preparation method and use
12/15/1999CN1047305C 可注射的组合物 Injectable compositions
12/14/1999US6001985 Fusion protein delivery systems and uses thereof
12/14/1999US6001870 Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media
12/14/1999US6001853 Composition further comprising a reducing agent for maintaining the hydroxylamine in a reduced form.
12/14/1999US6001817 In nucleotide carrier; anticancer agents; aids therapy
12/14/1999US6001644 Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
12/14/1999US6001395 Polymeric lamellar substrate particles for drug delivery
12/14/1999US6001392 Antitussive drugs delivered by ion exchange resins
12/14/1999US6001391 Molding a melt of a polymeric binder with or without at least one active ingredient, there being at least one solid product, which may contain an active ingredient incorporated into the still plastic composition during the molding step
12/14/1999US6001390 Formulations for transdermal delivery of pergolide
12/14/1999US6001386 For treatment of uveitis eye disease
12/14/1999US6001385 Solid products produced by extruding and/or injection moulding raw materials based on destructurized starch and/or containing starch, which products are intended for transdermal applications
12/14/1999US6001364 Comprising a baseplate structure having a plurality of oxime bonds, wherein each oxime bond links a specifically active molecule to the baseplate; for inducing an immune response in an animal
12/14/1999US6001347 Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
12/14/1999US6001336 Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
12/14/1999US6001335 Synthesizing a lipid vesicle having a gas encapsulated therein for ultrasonic imaging, by subjecting a solvent-free composition of a gaseous precursor and lipid in aqueous medium to a first pressure, then a second lower pressure
12/14/1999US6001334 Barium powder of large, medium and small particle sizes in specific weight ratios, coated with a composite additive of gum tragacanth and carageenan in specific ratios depending on particle size and surface area; no parasympatholytic agents
1 ... 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 ... 1712